My impression is that since the Cochrane report on tamiflu, and subsequent BARDA pull out of LANI, nobody is interested. Certainly the company has gone very quiet on it - no mention in their annual report. At a guess, probability of LANI going anywhere would be approaching zero.
Seems appropriate course of action, at this time, is to attempt to sell everything and return all funds to shareholders.
My impression is that since the Cochrane report on tamiflu, and...
Add to My Watchlist
What is My Watchlist?